YAP1 and pancreatic adenocarcinoma: As the most important effector of the Hippo pathway, YAP can also synergize with AP-1 to initiate carcinogenic processes in pancreatic ductal cells [19], whereas YAP deletion can hamper the progression of PAAD in Kras-mutant mice [21, 22].